Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2004

View Archived Issues

Nuvelo reports preliminary data from phase II study of alfimeprase in PAO

Preliminary data on long-term rosiglitazone for Cushing's disease

Subcutaneous TH-9507 shows promise for chronic wasting conditions

LY-156735 found effective and safe in primary insomnia

Potential benefits of BW-755C in metabolic dysfunction caused by high fructose diet in rats

Novartis seeks European approval of Xolair for severe allergic asthma

Canadian approval for initiation of phase II study of I.E.T. for MS

Approvable letter for Agilect in Parkinson's disease

Indaflex demonstrates significant localized antiinflammatory activity

Provalis signs vaccine option agreement with Chiron Vaccines

GlaxoSmithKline renews Crucell PER.C6 license agreement

Nymox pursues new approaches to combating Alzheimer's disease

Phosmidosine derivatives with antitumor activity presented by Sankyo

Solvay researchers describe series of 5-HT3 receptor antagonists

Aventis Pharma scientists design new protein kinase inhibitors

Boehringer Ingelheim presents compounds for inflammatory and obstructive airways diseases

Cadila claims aralkyl derivatives as antidiabetic, hypolipidemic and hypocholesterolemic compounds

Antifungal triazole prodrugs described in Sankyo patent

First description of lipoptosis using IgM antibody SAM-6

Tropical plant derivative induces mitochondria-dependent apoptosis in vitro

PARG inhibitor effective in vivo in septic shock-like syndrome, PARG may be novel therapeutic target

HKI-272 shows promise in the treatment of HER-2-positive tumors

Greater patient satisfaction achieved with inhaled insulin over subcutaneous insulin in diabetes

Patent claims new method to treat GI disorders with duloxetine

PROactive trial evaluates cardiovascular effects of pioglitazone in diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...